Hematology News

A small cohort of patients with sickle cell disease underwent successful hematopoietic stem cell transplantation from non-HLA matched donors, a group previously thought to be incompatible.

Women who recently had abortions had double the risk for venous thromboembolism of women who were not pregnant, study data showed.

Rivaroxaban significantly reduced venous thromboembolism recurrence among patients who had cancer and VTE compared with dalteparin, according to findings published in Journal of Clinical Oncology.

In a new cohort study, compared with estimates by the U.S. Preventive Services Task Force, risk for fatal or nonfatal gastrointestinal bleeding was higher in people without CVD not receiving antiplatelet therapy.

Longer donor leukocyte telomere length appeared associated with reduced infection-related mortality among patients with severe aplastic anemia who underwent hematopoietic stem cell transplantation, according to study results.

Longer donor leukocyte telomere length appeared associated with reduced infection-related mortality among patients with severe aplastic anemia who underwent hematopoietic stem cell transplantation, according to study results.

The FDA granted priority review to emicizumab-kxwh for treatment of adults and children with hemophilia A without factor VIII inhibitors, according to the agent’s manufacturer.

The FDA granted priority review designation to eltrombopag in combination with standard immunosuppressive therapy for the first-line treatment of severe aplastic anemia, according to the manufacturer.

Results of two phase 3 trials showed that Doptelet significantly reduced the need for platelet transfusions or rescue procedures for bleeding compared with placebo in patients with thrombocytopenia and chronic liver disease who underwent a scheduled procedure.

The FDA approved avatrombopag to treat low blood platelet count among adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.